US 11439641
Pyrimidine JAK inhibitors for the treatment of skin diseases
granted A61KA61K31/506A61K9/06
Quick answer
US patent 11439641 (Pyrimidine JAK inhibitors for the treatment of skin diseases) held by Theravance Biopharma R&D IP, LLC expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/506, A61K9/06, A61P, A61P17/00